nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1A2—Carmustine—malignant glioma	0.319	0.569	CbGbCtD
Flutamide—CYP3A4—Temozolomide—malignant glioma	0.241	0.43	CbGbCtD
Flutamide—Metastatic neoplasm—Temozolomide—malignant glioma	0.0188	0.12	CcSEcCtD
Flutamide—Nilutamide—POR—malignant glioma	0.0185	1	CrCbGaD
Flutamide—Traumatic liver injury—Temozolomide—malignant glioma	0.00968	0.0616	CcSEcCtD
Flutamide—Transaminases increased—Carmustine—malignant glioma	0.00614	0.039	CcSEcCtD
Flutamide—Interstitial lung disease—Carmustine—malignant glioma	0.00527	0.0336	CcSEcCtD
Flutamide—Interstitial lung disease—Temozolomide—malignant glioma	0.0051	0.0324	CcSEcCtD
Flutamide—Herpes zoster—Temozolomide—malignant glioma	0.00479	0.0305	CcSEcCtD
Flutamide—Liver injury—Temozolomide—malignant glioma	0.00429	0.0273	CcSEcCtD
Flutamide—Pulmonary embolism—Carmustine—malignant glioma	0.00373	0.0238	CcSEcCtD
Flutamide—Pulmonary embolism—Temozolomide—malignant glioma	0.00361	0.023	CcSEcCtD
Flutamide—Neoplasm—Carmustine—malignant glioma	0.00337	0.0215	CcSEcCtD
Flutamide—Gynaecomastia—Carmustine—malignant glioma	0.00334	0.0213	CcSEcCtD
Flutamide—Neoplasm—Temozolomide—malignant glioma	0.00326	0.0208	CcSEcCtD
Flutamide—Diabetes mellitus—Carmustine—malignant glioma	0.00312	0.0198	CcSEcCtD
Flutamide—Hot flush—Temozolomide—malignant glioma	0.0028	0.0178	CcSEcCtD
Flutamide—Menopausal symptoms—Temozolomide—malignant glioma	0.00278	0.0177	CcSEcCtD
Flutamide—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00236	0.015	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00236	0.015	CcSEcCtD
Flutamide—Hyperglycaemia—Carmustine—malignant glioma	0.00211	0.0134	CcSEcCtD
Flutamide—Erectile dysfunction—Temozolomide—malignant glioma	0.00208	0.0133	CcSEcCtD
Flutamide—Photosensitivity reaction—Temozolomide—malignant glioma	0.00207	0.0131	CcSEcCtD
Flutamide—Hyperglycaemia—Temozolomide—malignant glioma	0.00204	0.013	CcSEcCtD
Flutamide—Oedema peripheral—Carmustine—malignant glioma	0.00185	0.0117	CcSEcCtD
Flutamide—Hepatitis—Temozolomide—malignant glioma	0.00181	0.0115	CcSEcCtD
Flutamide—Oedema peripheral—Temozolomide—malignant glioma	0.00178	0.0114	CcSEcCtD
Flutamide—Erythema—Carmustine—malignant glioma	0.00163	0.0104	CcSEcCtD
Flutamide—Erythema—Temozolomide—malignant glioma	0.00158	0.01	CcSEcCtD
Flutamide—Anaemia—Carmustine—malignant glioma	0.00151	0.0096	CcSEcCtD
Flutamide—Ill-defined disorder—Temozolomide—malignant glioma	0.00146	0.00931	CcSEcCtD
Flutamide—Leukopenia—Carmustine—malignant glioma	0.00146	0.00929	CcSEcCtD
Flutamide—Anaemia—Temozolomide—malignant glioma	0.00146	0.00927	CcSEcCtD
Flutamide—Malaise—Temozolomide—malignant glioma	0.00142	0.00905	CcSEcCtD
Flutamide—Leukopenia—Temozolomide—malignant glioma	0.00141	0.00898	CcSEcCtD
Flutamide—Hypertension—Carmustine—malignant glioma	0.00141	0.00896	CcSEcCtD
Flutamide—Anxiety—Carmustine—malignant glioma	0.00138	0.00881	CcSEcCtD
Flutamide—Hypertension—Temozolomide—malignant glioma	0.00136	0.00866	CcSEcCtD
Flutamide—Confusional state—Carmustine—malignant glioma	0.00134	0.00854	CcSEcCtD
Flutamide—Anxiety—Temozolomide—malignant glioma	0.00134	0.00851	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00133	0.00848	CcSEcCtD
Flutamide—Oedema—Carmustine—malignant glioma	0.00133	0.00847	CcSEcCtD
Flutamide—Discomfort—Temozolomide—malignant glioma	0.00133	0.00844	CcSEcCtD
Flutamide—Thrombocytopenia—Carmustine—malignant glioma	0.0013	0.0083	CcSEcCtD
Flutamide—Confusional state—Temozolomide—malignant glioma	0.0013	0.00826	CcSEcCtD
Flutamide—Oedema—Temozolomide—malignant glioma	0.00129	0.00819	CcSEcCtD
Flutamide—Anorexia—Carmustine—malignant glioma	0.00127	0.00808	CcSEcCtD
Flutamide—Thrombocytopenia—Temozolomide—malignant glioma	0.00126	0.00802	CcSEcCtD
Flutamide—Skin disorder—Temozolomide—malignant glioma	0.00125	0.00795	CcSEcCtD
Flutamide—Anorexia—Temozolomide—malignant glioma	0.00123	0.00781	CcSEcCtD
Flutamide—Insomnia—Carmustine—malignant glioma	0.0012	0.00766	CcSEcCtD
Flutamide—Somnolence—Carmustine—malignant glioma	0.00118	0.00753	CcSEcCtD
Flutamide—Insomnia—Temozolomide—malignant glioma	0.00116	0.00741	CcSEcCtD
Flutamide—Decreased appetite—Carmustine—malignant glioma	0.00116	0.00737	CcSEcCtD
Flutamide—Somnolence—Temozolomide—malignant glioma	0.00114	0.00728	CcSEcCtD
Flutamide—Constipation—Carmustine—malignant glioma	0.00114	0.00725	CcSEcCtD
Flutamide—Decreased appetite—Temozolomide—malignant glioma	0.00112	0.00712	CcSEcCtD
Flutamide—Fatigue—Temozolomide—malignant glioma	0.00111	0.00706	CcSEcCtD
Flutamide—Constipation—Temozolomide—malignant glioma	0.0011	0.007	CcSEcCtD
Flutamide—Feeling abnormal—Carmustine—malignant glioma	0.0011	0.00698	CcSEcCtD
Flutamide—Feeling abnormal—Temozolomide—malignant glioma	0.00106	0.00675	CcSEcCtD
Flutamide—Asthenia—Carmustine—malignant glioma	0.000956	0.00608	CcSEcCtD
Flutamide—Asthenia—Temozolomide—malignant glioma	0.000923	0.00588	CcSEcCtD
Flutamide—Diarrhoea—Carmustine—malignant glioma	0.000911	0.0058	CcSEcCtD
Flutamide—Pruritus—Temozolomide—malignant glioma	0.000911	0.00579	CcSEcCtD
Flutamide—Dizziness—Carmustine—malignant glioma	0.000881	0.0056	CcSEcCtD
Flutamide—Diarrhoea—Temozolomide—malignant glioma	0.000881	0.0056	CcSEcCtD
Flutamide—Dizziness—Temozolomide—malignant glioma	0.000851	0.00542	CcSEcCtD
Flutamide—Vomiting—Carmustine—malignant glioma	0.000847	0.00539	CcSEcCtD
Flutamide—Rash—Carmustine—malignant glioma	0.00084	0.00534	CcSEcCtD
Flutamide—Dermatitis—Carmustine—malignant glioma	0.000839	0.00534	CcSEcCtD
Flutamide—Headache—Carmustine—malignant glioma	0.000834	0.00531	CcSEcCtD
Flutamide—Vomiting—Temozolomide—malignant glioma	0.000818	0.00521	CcSEcCtD
Flutamide—Rash—Temozolomide—malignant glioma	0.000811	0.00516	CcSEcCtD
Flutamide—Dermatitis—Temozolomide—malignant glioma	0.000811	0.00516	CcSEcCtD
Flutamide—Headache—Temozolomide—malignant glioma	0.000806	0.00513	CcSEcCtD
Flutamide—Nausea—Carmustine—malignant glioma	0.000791	0.00503	CcSEcCtD
Flutamide—Nausea—Temozolomide—malignant glioma	0.000764	0.00486	CcSEcCtD
Flutamide—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000162	0.000613	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—CDKN2B—malignant glioma	0.00016	0.000606	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	0.00016	0.000605	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.00016	0.000605	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00016	0.000604	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—AKT1—malignant glioma	0.000159	0.000604	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—PTGS1—malignant glioma	0.000159	0.000602	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000156	0.000589	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000153	0.000578	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NCOR1—malignant glioma	0.000152	0.000575	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.000151	0.000572	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MYC—malignant glioma	0.000151	0.000571	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	0.00015	0.000569	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000149	0.000564	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ASMT—malignant glioma	0.000148	0.00056	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—malignant glioma	0.000147	0.000558	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000145	0.000548	CbGpPWpGaD
Flutamide—AR—Gene Expression—DNMT3B—malignant glioma	0.000142	0.000537	CbGpPWpGaD
Flutamide—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.00014	0.000531	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—KRAS—malignant glioma	0.000139	0.000527	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—BCAN—malignant glioma	0.000139	0.000527	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.000138	0.000522	CbGpPWpGaD
Flutamide—AR—Gene Expression—HIST1H3B—malignant glioma	0.000138	0.000522	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000137	0.000518	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	0.000136	0.000514	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000133	0.000505	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000131	0.000496	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000129	0.000489	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.000127	0.00048	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	0.000125	0.000473	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.000124	0.00047	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.000124	0.00047	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—malignant glioma	0.000124	0.000469	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000123	0.000465	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	0.000122	0.000462	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—RTEL1—malignant glioma	0.000119	0.00045	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.000118	0.000448	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.000118	0.000448	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—GSTP1—malignant glioma	0.000118	0.000445	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.000117	0.000444	CbGpPWpGaD
Flutamide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000117	0.000444	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	0.000116	0.00044	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	0.000116	0.000439	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	0.000115	0.000437	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000115	0.000436	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—COX8A—malignant glioma	0.000113	0.000429	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—IDH2—malignant glioma	0.000112	0.000425	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000109	0.000413	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—PPARG—malignant glioma	0.000109	0.000412	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—COX8A—malignant glioma	0.000107	0.000406	CbGpPWpGaD
Flutamide—AR—Gene Expression—H3F3A—malignant glioma	0.000106	0.000403	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	0.000106	0.000401	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000106	0.0004	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000106	0.0004	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP2B6—malignant glioma	0.000105	0.000399	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—AKT1—malignant glioma	0.000104	0.000396	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	0.000103	0.000388	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH3—malignant glioma	9.99e-05	0.000378	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ASMT—malignant glioma	9.64e-05	0.000365	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—IDH1—malignant glioma	9.64e-05	0.000365	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.58e-05	0.000363	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SPHK1—malignant glioma	9.33e-05	0.000353	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—RTEL1—malignant glioma	9.18e-05	0.000348	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP2C18—malignant glioma	9.14e-05	0.000346	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—ASMT—malignant glioma	9.11e-05	0.000345	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	9.08e-05	0.000344	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—BCAN—malignant glioma	9.07e-05	0.000343	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH2—malignant glioma	8.96e-05	0.000339	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	8.95e-05	0.000339	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.9e-05	0.000337	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—COX8A—malignant glioma	8.77e-05	0.000332	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	8.66e-05	0.000328	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	8.62e-05	0.000326	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—BCAN—malignant glioma	8.57e-05	0.000324	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.5e-05	0.000322	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	8.23e-05	0.000311	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.85e-05	0.000297	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	7.84e-05	0.000297	CbGpPWpGaD
Flutamide—AR—Gene Expression—CDKN2B—malignant glioma	7.7e-05	0.000292	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.58e-05	0.000287	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ASMT—malignant glioma	7.46e-05	0.000282	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTT1—malignant glioma	7.39e-05	0.00028	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—IDH2—malignant glioma	7.31e-05	0.000277	CbGpPWpGaD
Flutamide—AR—Gene Expression—NCOR1—malignant glioma	7.31e-05	0.000277	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	7.29e-05	0.000276	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—BCAN—malignant glioma	7.01e-05	0.000265	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS1—malignant glioma	6.93e-05	0.000262	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—IDH2—malignant glioma	6.9e-05	0.000261	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.9e-05	0.000261	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2B6—malignant glioma	6.87e-05	0.00026	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—COX8A—malignant glioma	6.83e-05	0.000259	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.51e-05	0.000247	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP2B6—malignant glioma	6.49e-05	0.000246	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—BCHE—malignant glioma	6.44e-05	0.000244	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—SLC5A5—malignant glioma	6.36e-05	0.000241	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—IDH1—malignant glioma	6.28e-05	0.000238	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—malignant glioma	6.2e-05	0.000235	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.11e-05	0.000231	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SPHK1—malignant glioma	6.08e-05	0.00023	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.02e-05	0.000228	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.96e-05	0.000226	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2C18—malignant glioma	5.96e-05	0.000226	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—IDH1—malignant glioma	5.94e-05	0.000225	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ASMT—malignant glioma	5.81e-05	0.00022	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SPHK1—malignant glioma	5.75e-05	0.000218	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.68e-05	0.000215	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—IDH2—malignant glioma	5.65e-05	0.000214	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CYP2C18—malignant glioma	5.63e-05	0.000213	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH1—malignant glioma	5.55e-05	0.00021	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—BCAN—malignant glioma	5.46e-05	0.000207	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.33e-05	0.000202	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2B6—malignant glioma	5.31e-05	0.000201	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.31e-05	0.000201	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—COX8A—malignant glioma	5.27e-05	0.0002	CbGpPWpGaD
Flutamide—AR—Gene Expression—PPARG—malignant glioma	5.24e-05	0.000198	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.2e-05	0.000197	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—GSTP1—malignant glioma	5.12e-05	0.000194	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CAT—malignant glioma	4.99e-05	0.000189	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—IDH1—malignant glioma	4.86e-05	0.000184	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.83e-05	0.000183	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTT1—malignant glioma	4.82e-05	0.000182	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—NCOR1—malignant glioma	4.71e-05	0.000178	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SPHK1—malignant glioma	4.7e-05	0.000178	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.67e-05	0.000177	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CYP2C18—malignant glioma	4.61e-05	0.000174	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTT1—malignant glioma	4.55e-05	0.000172	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS1—malignant glioma	4.52e-05	0.000171	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—ASMT—malignant glioma	4.48e-05	0.00017	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—IDH2—malignant glioma	4.4e-05	0.000167	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.34e-05	0.000164	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS1—malignant glioma	4.27e-05	0.000162	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.25e-05	0.000161	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BCAN—malignant glioma	4.22e-05	0.00016	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—BCHE—malignant glioma	4.2e-05	0.000159	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.15e-05	0.000157	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—SLC5A5—malignant glioma	4.15e-05	0.000157	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2B6—malignant glioma	4.14e-05	0.000157	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—BCHE—malignant glioma	3.97e-05	0.00015	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.96e-05	0.00015	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—SLC5A5—malignant glioma	3.92e-05	0.000148	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CAV1—malignant glioma	3.84e-05	0.000145	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.82e-05	0.000145	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—IDH1—malignant glioma	3.79e-05	0.000143	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTT1—malignant glioma	3.73e-05	0.000141	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.7e-05	0.00014	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.67e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.67e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SPHK1—malignant glioma	3.66e-05	0.000139	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.59e-05	0.000136	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CG—malignant glioma	3.5e-05	0.000132	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS1—malignant glioma	3.49e-05	0.000132	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.48e-05	0.000132	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—IDH2—malignant glioma	3.4e-05	0.000129	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.38e-05	0.000128	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PPARG—malignant glioma	3.37e-05	0.000128	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—GSTP1—malignant glioma	3.34e-05	0.000126	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CAT—malignant glioma	3.25e-05	0.000123	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—BCHE—malignant glioma	3.25e-05	0.000123	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—SLC5A5—malignant glioma	3.21e-05	0.000121	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.2e-05	0.000121	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.19e-05	0.000121	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—GSTP1—malignant glioma	3.16e-05	0.000119	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.08e-05	0.000117	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CD—malignant glioma	3.07e-05	0.000116	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CAT—malignant glioma	3.07e-05	0.000116	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—NCOR1—malignant glioma	3.07e-05	0.000116	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.03e-05	0.000115	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3e-05	0.000114	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—malignant glioma	2.99e-05	0.000113	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.98e-05	0.000113	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—IDH1—malignant glioma	2.92e-05	0.000111	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTT1—malignant glioma	2.9e-05	0.00011	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—NCOR1—malignant glioma	2.9e-05	0.00011	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SPHK1—malignant glioma	2.83e-05	0.000107	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.77e-05	0.000105	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS1—malignant glioma	2.72e-05	0.000103	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.71e-05	0.000103	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CB—malignant glioma	2.68e-05	0.000101	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTGS2—malignant glioma	2.65e-05	0.000101	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.62e-05	9.92e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—GSTP1—malignant glioma	2.58e-05	9.78e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—BCHE—malignant glioma	2.53e-05	9.57e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CAT—malignant glioma	2.51e-05	9.51e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CAV1—malignant glioma	2.5e-05	9.47e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.5e-05	9.46e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—NCOR1—malignant glioma	2.37e-05	8.99e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—CAV1—malignant glioma	2.36e-05	8.95e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.36e-05	8.94e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.34e-05	8.86e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PTEN—malignant glioma	2.31e-05	8.77e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.28e-05	8.63e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.26e-05	8.55e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTT1—malignant glioma	2.24e-05	8.48e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PPARG—malignant glioma	2.2e-05	8.33e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—malignant glioma	2.15e-05	8.15e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS1—malignant glioma	2.1e-05	7.95e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PPARG—malignant glioma	2.08e-05	7.87e-05	CbGpPWpGaD
Flutamide—AR—Gene Expression—AKT1—malignant glioma	2.07e-05	7.84e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.04e-05	7.73e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—GSTP1—malignant glioma	2.01e-05	7.62e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CD—malignant glioma	2e-05	7.59e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CAT—malignant glioma	1.96e-05	7.41e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—BCHE—malignant glioma	1.95e-05	7.39e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—CAV1—malignant glioma	1.93e-05	7.32e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.93e-05	7.3e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.89e-05	7.17e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—NCOR1—malignant glioma	1.85e-05	7e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.85e-05	7e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.76e-05	6.67e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.75e-05	6.61e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTGS2—malignant glioma	1.73e-05	6.55e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PPARG—malignant glioma	1.7e-05	6.44e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.65e-05	6.25e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTGS2—malignant glioma	1.63e-05	6.19e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—PIK3CA—malignant glioma	1.63e-05	6.18e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—GSTP1—malignant glioma	1.55e-05	5.88e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.55e-05	5.87e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CAT—malignant glioma	1.51e-05	5.72e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PTEN—malignant glioma	1.51e-05	5.71e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—CAV1—malignant glioma	1.51e-05	5.71e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.44e-05	5.45e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—NCOR1—malignant glioma	1.43e-05	5.4e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PTEN—malignant glioma	1.43e-05	5.4e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.37e-05	5.2e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.35e-05	5.11e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTGS2—malignant glioma	1.34e-05	5.07e-05	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—AKT1—malignant glioma	1.33e-05	5.05e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PPARG—malignant glioma	1.32e-05	5.02e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.21e-05	4.57e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PTEN—malignant glioma	1.17e-05	4.42e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—CAV1—malignant glioma	1.16e-05	4.4e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.06e-05	4.03e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.06e-05	4.01e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.05e-05	3.98e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTGS2—malignant glioma	1.04e-05	3.95e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PPARG—malignant glioma	1.02e-05	3.87e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CA—malignant glioma	1.01e-05	3.81e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CD—malignant glioma	9.31e-06	3.53e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PTEN—malignant glioma	9.09e-06	3.44e-05	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—AKT1—malignant glioma	8.7e-06	3.29e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—PIK3CA—malignant glioma	8.23e-06	3.12e-05	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—AKT1—malignant glioma	8.22e-06	3.11e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.12e-06	3.07e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTGS2—malignant glioma	8.04e-06	3.05e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PTEN—malignant glioma	7.02e-06	2.66e-05	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—AKT1—malignant glioma	6.72e-06	2.55e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—PIK3CA—malignant glioma	6.41e-06	2.43e-05	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—AKT1—malignant glioma	5.24e-06	1.98e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.95e-06	1.87e-05	CbGpPWpGaD
Flutamide—CYP3A4—Metabolism—AKT1—malignant glioma	4.04e-06	1.53e-05	CbGpPWpGaD
